Introduction to ALFARIA
ALFARIA is a high-quality injectable formulation of Alpha Beta Arteether 150 mg, widely recognized for its role in treating severe malaria infections. Malaria, caused by Plasmodium falciparum, remains a serious health challenge in tropical and subtropical regions. In cases where oral medication is not possible or effective, injectable therapy becomes critical. ALFARIA Injection provides rapid therapeutic action, helping to reduce parasite load and minimize life-threatening complications.
Composition and Strength
Each vial of ALFARIA contains:
- Active Ingredient: Alpha Beta Arteether 150 mg.
- Dosage Form: Sterile injection.
- Packaging: Supplied in a tray pack for safety and convenient handling.
Alpha Beta Arteether belongs to the class of artemisinin derivatives, well-known for their fast and potent antimalarial properties.
Therapeutic Indications
ALFARIA Injection is prescribed for a range of severe malaria cases, particularly when urgent treatment is necessary.
Severe Falciparum Malaria
ALFARIA is highly effective in the treatment of Plasmodium falciparum malaria, especially in patients with complicated or resistant strains.
Cases Where Oral Therapy is Not Possible
For critically ill patients who cannot take oral medications due to vomiting, unconsciousness, or severe weakness, ALFARIA provides immediate relief via injection.
Pediatric and Adult Use
This injection can be safely administered under medical supervision to both adults and children, making it a versatile choice for hospitals and clinics in malaria-prone areas.
Benefits of ALFARIA Injection
Alpha Beta Arteether injection offers multiple benefits for both patients and healthcare professionals:
- Fast-Acting Relief: Provides quick action against malaria parasites in the bloodstream.
- High Cure Rates: Effective in managing severe and drug-resistant malaria strains.
- WHO-Recommended Therapy: Recognized as a standard treatment in severe malaria cases.
- Reduced Mortality Risk: Helps in saving lives by rapidly decreasing parasite density.
- Convenient Packaging: Tray packs ensure ease of use, safe storage, and transport.
Packaging & Quality Standards
ALFARIA Injection is supplied in secure tray packaging to maintain sterility and ensure proper handling. Each vial undergoes stringent testing before being released to the market.
- Manufactured under WHO-GMP certified facilities, ensuring global quality benchmarks.
- Tested for purity, potency, and safety at every production stage.
- Supplied in sterile packaging suitable for hospitals, healthcare centers, and clinics.
Healthcare providers can rely on ALFARIA for its safety, consistency, and therapeutic effectiveness in managing malaria emergencies.
Conclusion
ALFARIA (Alpha Beta Arteether 150 mg Injection) is a trusted solution for the treatment of severe and complicated malaria cases. With its fast-acting therapeutic effect, high cure rates, WHO-GMP certified manufacturing, and safe tray packaging, it stands out as a reliable choice for healthcare providers in malaria-endemic regions.
By delivering rapid relief and ensuring safe patient outcomes, ALFARIA Injection continues to play an important role in the fight against malaria.